The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Senchukova M.A.

Orenburg State Medical University, Ministry of Health of Russia, Orenburg

Ryabov A.B.

Hertsen Moscow Oncology Research Center, Moscow, Russia

Modern concepts of factors for gastric cancer progression

Authors:

Senchukova M.A., Ryabov A.B.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2016;5(1): 82‑87

DOI: 10.17116/onkolog20165182-87

Read: 1462 times

Download PDF (RU)
Contact the author
Table of contents

MODERN CONCEPTS OF FACTORS FOR GASTRIC CANCER PROGRESSION
MODERN CONCEPTS OF FACTORS FOR GASTRIC CANCER PROGRESSION

To cite this article:

Senchukova MA, Ryabov AB. Modern concepts of factors for gastric cancer progression. P.A. Herzen Journal of Oncology. 2016;5(1):82‑87. (In Russ.)
https://doi.org/10.17116/onkolog20165182-87

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The paper reviews clinical, morphological, and molecular genetic factors for gastric cancer progression. Particular emphasis is placed on the role of angiogenesis and inflammation in initiating the invasion and metastasis of gastric cancer. Analysis of the scientific literature could concentrate attention on the most important aspects of gastric cancer progression and highlight their value in estimating disease prognosis and in elaborating new approaches to treating this pathology.

Keywords:

gastric cancer
factors for tumor progression
inflammation
angiogenesis

Authors:

Senchukova M.A.

Orenburg State Medical University, Ministry of Health of Russia, Orenburg

Ryabov A.B.

Hertsen Moscow Oncology Research Center, Moscow, Russia

Close metadata

References:

  1. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2009;71(2):127-164. doi:10.1016/j.critrevonc.2009.01.004.
  2. Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012;4(7):156-169. doi:10.4251/wjgo.v4.i7.156.
  3. Zlokachestvennye novoobrazovaniya v Rossii v 2012 godu (zabolevaemost' i smertnost'). Pod red. Kaprina A.D., Starinskogo V.V., Petrovoi G.V. M.: FGBU «MNIOI im. P.A. Gertsena»; 2014. Dostupno po: http://www.oncology.ru/service/statistics/malignant_tumors/2012.pdf. Ssylka aktivna na 15.06.2015.
  4. Khedmat H, Panahian M, Mashahdian M, Rajabpour MV, Zendehdel K. Prognostic factors and survival in stomach cancer — analysis of 15 years of data from a referral hospital in iran and evaluation of international variation. Onkologie. 2011;34(4):178-182. doi:10.1159/000327007.
  5. Sostoyanie onkologicheskoi pomoshchi Rossii v 2012 godu. Pod red. Kaprina A.D., Starinskogo V.V., Petrovoi G.V. M.: FGBU «MNIOI im. P.A. Gertsena»; 2014. Dostupno po: http://www.oncology.ru/service/statistics/condition/2012.pdf. Ssylka aktivna na 15.06.2015.
  6. Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14(4):301-316. doi:10.1007/s10120-011-0085-6.
  7. Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16(1):1-27. doi:10.1007/s10120-012-0163-4.
  8. Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, Murata K et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol. 2004; 39(4):380-384. doi:10.1080/00365520310008629.
  9. An JY, Baik YH, Choi MG, Noh JH, Sohn TS, Kim S. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg. 2007;246(5):749-753. doi:10.1097/sla.0b013e31811f3fb7.
  10. Bilici A, Seker M, Ustaalioglu BB, Yilmaz B, Doventas A, Salepci  T, Gumus M. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer. Med Oncol. 2010;27(3):975-984. doi:10.1007/s12032-009-9319-4.
  11. Lee SY, Hwang I, Park YS, Gardner J, Ro JY. Metastatic lymph node ratio in advanced gastric carcinoma: a better prognostic factor than number of metastatic lymph nodes? Int J Oncol. 2010;36(6):1461-1467. doi:10.3892/ijo_00000632.
  12. Liu X, Long Z, Cai H, Huang H, Shi Y, Wang Y. Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer. PLoS One. 2014;9(8):e105112. doi:10.1371/journal.pone.0105112.
  13. Shen L, Huang Y, Sun M, Xu H, Wei W, Wu W. Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single-institution experience in China. Can J Gastroenterol. 2009;23(5):353-356. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706748/ Accessed June 15, 2015.
  14. Lazar D, Taban S, Dema A, Cornianu M, Goldiş A, Raţiu I, Sporea I. Gastric cancer: the correlation between the clinicopathological factors and patients’ survival (I). Rom J Morphol Embryol. 2009;50(1):41-50. Available at: http://www.rjme.ro/RJME/resources/files/500109041050.pdf/ Accessed June 15, 2015.
  15. Lazar D, Taban S, Sporea I, Dema A, Cornianu M, Lazar E et al. Gastric cancer: correlation between clinicopathological factors and survival of patients (II). Rom J Morphol Embryol. 2009;50(2):185-194. Available at: http://www.rjme.ro/RJME/resources/files/500209185194.pdf/ Accessed June 15, 2015.
  16. Wang YD, Wu P, Mao JD, Huang H, Zhang F. Relationship between vascular invasion and microvessel density and micrometastasis. World J Gastroenterol. 2007;46(13):6269-6273. doi:10.3748/wjg.v13.i46.6269.
  17. Zheng L, Wu C, Xi P, Zhu M, Zhang L, Chen S et al. The survival and the long-term trends of patients with gastric cancer in Shanghai, China. BMC Cancer. 2014;14:300. doi:10.1186/1471-2407-14-300.
  18. Deans C, Yeo MS, Soe M, Shabbir A, Ti TK, So JB. Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011;35(3):617-624. doi:10.1007/s00268-010-0935-0.
  19. Park JC, Lee YC, Kim JH, Kim YJ, Lee SK, Hyung WJ et al. Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol. 2009;99(7):395-401.  doi:10.1002/jso.21281.
  20. Tavares A, Gandra A, Viveiros F, Cidade C, Maciel J. Analysis of clinicopathologic characteristics and prognosis of gastric cancer in young and older patients. Pathol Oncol Res. 2013;19(1):111-117.  doi:10.1007/s12253-012-9530-z.
  21. Zavalishina L.A. Molekulyarno-biologicheskie faktory invazivnogo rosta i metastazirovaniya raka pri morfologicheskom issledovanii: Avtoref. diss. ... d-ra biol. nauk. M.; 2006. Dostupno po: http://www.rosoncoweb.ru/library/dissertation/14.00.14/003.pdf. Ssylka aktivna na 15.06.2015.
  22. Lud A.N. Znachenie molekulyarno-biologicheskikh markerov pri rake zheludka i pishchevoda. Rossiiskii bioterapevticheskii zhurnal. 2007;3:38-42. Dostupno po: http://www.ronc.ru/attachments/article/2063/rbj-3-tom6-2007.pdf. Ssylka aktivna na 15.06.2015.
  23. Zav'yalova M.V., Perel'muter V.M., Stepanov I.V., Afanas'ev S.G., Avgustinovich A.V. Rol' invazivnykh svoistv opukholi v razvitii limfogennogo metastazirovaniya pri kishechnom i diffuznom tipakh raka zheludka. Sibirskii onkologicheskii zhurnal. 2011;1:16-20. Dostupno po: http://oncology.tomsk.ru/nii/journal/2011/1/files/soj_2011_1_16-20.pdf. Ssylka aktivna na 15.06.2015.
  24. Lee KE, Lee H-J, Kim YH. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jap J Clin Oncol. 2003;33:173-179.  doi:10.1093/jjco/hyg039.
  25. Kim YJ, Kim MA, Im SA, Kim TM, Kim DW, Yang HK et al. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. Cancer Invest. 2008;26(2):152-158.  doi:10.1080/07357900701518909.
  26. Bendas G, Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol. 2012;2012:676731. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296185/ Accessed June 15, 2015. doi:10.1155/2012/676731.
  27. Laubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol. 2010;20(3):169-177.  doi:10.1016/j.semcancer.2010.04.005.
  28. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer. 2008;8(8):604-617.  doi:10.1038/nrc2353.
  29. Mayrbaeur B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W et al. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Eur J Gastroenterol Hepatol. 2010;22(3):306-310.  doi:10.1097/meg.0b013e32832bab9a.
  30. Chu YQ, Ye ZY, Tao HQ, Wang YY, Zhao ZS. Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma. World J Gastroenterol. 2008;14(13):1990-1996. doi:10.3748/wjg.14.1990.
  31. Zhou Y, Li G, Wu J, Zhang Z, Wu Z, Fan P et al. Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumour Biol. 2010;31(6):549-558.  doi:10.1007/s13277-010-0068-y.
  32. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res. 2006;26(5A):3579-3583. Available at: http://ar.iiarjournals.org/content/26/5A/3579.long. Accessed June 15, 2015.
  33. Osinsky S, Bubnovskaya L, Ganusevich I, Kovelskaya A, Gumenyuk L, Olijnichenko G, Merentsev S. Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival. Clin Transl Oncol. 2011;13(2):133-138.  doi:10.1007/s12094-011-0630-0.
  34. Yang Q, Ye ZY, Zhang JX, Tao HQ, Li SG, Zhao ZS. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Anat Rec (Hoboken). 2010;293(12):2012-2019. doi:10.1002/ar.21071.
  35. Folkman J. Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. Endocrinology. 1998;139(2):441-442. Available at: http://press.endocrine.org/doi/10.1210/endo.139.2.5858?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&. Accessed June 15, 2015.
  36. Ferrara N. Timeline: VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2:795-803.  doi:10.1038/nrc909.
  37. Kerbel R. Tumor angiogenesis: past, present and the near future. Carcinogenesis. 2000;21(3):505-515.  doi:10.1093/carcin/21.3.505.
  38. Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviya. M.: Meditsina; 1995.
  39. Ma J, Zhang L, Ru GQ, Zhao ZS, Xu WJ. Upregulation of hypoxia inducible factor 1α mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol. 2007;13(11):1680-1686. doi:10.3748/wjg.v13.i11.1680.
  40. Zhan H, Liang H, Liu X, Deng J, Wang B, Hao X. Expression of Rac1, HIF-1α, and VEGF in gastric carcinoma: correlation with angiogenesis and prognosis. Onkologie. 2013;36(3):102-107.  doi:10.1159/000348525.
  41. Isobe T, Aoyagi K, Koufuji K, Shirouzu K, Kawahara A, Taira T, Kage M. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer. Int J Clin Oncol. 2013;18(2):293-304.  doi:10.1007/s10147-012-0378-8.
  42. Lazar D, Taban S, Raika M, Sporea I, Cornianu M, Goldiş A, Vernic C. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers. Rom J Morphol Embryol. 2008;49(2):137-148. Available at: http://www.rjme.ro/RJME/resources/files/490208137148.pdf. Accessed June 15, 2015.
  43. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Ehi K, Arima  H et al. Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. J Surg Oncol. 2009;99(3):148-153.  doi:10.1002/jso.21228.
  44. Wang X, Chen X, Fang J, Yang C. Overexpression of both VEGF- A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth. Int J Clin Exp Pathol. 2013;6(4):586-597. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606848/ Accessed June 15, 2015.
  45. Wang XL, Fang JP, Tang RY, Chen XM. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases. BMC Cancer. 2010;10:299.  doi:10.1186/1471-2407-10-299.
  46. Zor'kin V.T., Lazarev A.F., Klimachev V.V., Bobrov I.P., Avdalyan A.M. Immunomorfologicheskaya kharakteristika protsessa neovaskulyarizatsii v metastaziruyushchikh adenokartsinomakh zheludka s primeneniem markerov Her2/new, Ki-67 i p53. Sibirskii onkologicheskii zhurnal. 2006;3:104-106. Dostupno po: http://www.oncology.tomsk.ru/nii/journal/2006/3/information/soj_2006_3_81-130.pdf. Ssylka aktivna na 15.06.2015.
  47. Elpek GO, Gelen T, Aksoy NH. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma. Pathol Oncol Res. 2000;6:59-64.  doi:10.1007/bf03032660.
  48. MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu  P, Resnick MI, Gupta S. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol. 2006;176:1012-1016. doi:http://dx.doi.org/10.1016/j.juro.2006.04.033.
  49. Robertson FM, Cristofanilli M. A global approach to inflammatory breast cancer. Future Oncol. 2011;7(1):25-30.  doi:10.2217/fon.10.177.
  50. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009;9(4):259-270.  doi:10.1038/nri2528.
  51. Eiro N, Vizoso FJ. Inflammation and cancer. World J Gastrointest Surg. 2012;4(3):62-72.  doi:10.4240/wjgs.v4.i3.62.
  52. Huang SP, Wu MS, Shun CT, Wang HP, Hsieh CY, Kuo ML, Lin JT. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci. 2005;12(1):229-241.  doi:10.1007/s11373-004-8177-5.
  53. Geng Y, Chandrasekaran S, Hsu JW, Gidwani M, Hughes AD, King MR. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. PLoS One. 2013;8(1):e54959. doi:10.1371/journal.pone.0054959.
  54. Robinson SC, Scott KA, Balkwill FR. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur J Immunol. 2002;32:404-412.  doi:10.1002/1521-4141(200202)32:2<404::aid-immu404­>3.0.co;2-x.
  55. Huang Y, Liao H, Zhang Y, Yuan R, Wang F, Gao Y et al. Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta-analysis. PLoS One. 2014;9(5):e94376. doi:10.1371/journal.pone.0094376.
  56. Novikov D.G. Osobennosti vospalitel'nogo infil'trata i atrofii v parakankroznoi i distantnoi zonakh slizistoi obolochki zheludka u bol'nykh rakom zheludka kishechnogo tipa, nositelei polimorfnykh allelei genov tsitokinov. Molodoi uchenyi. 2012;3:447-452. Dostupno po: http://www.moluch.ru/archive/38/4485/ Ssylka aktivna na 15.06.2015.
  57. Chen LJ, Zheng X, Shen YP, Zhu YB, Li Q, Chen J et al. Higher numbers of T-bet(+) intra-tumoral lymphoid cells correlate with better survival in gastric cancer. Cancer Immunol Immunother. 2013;62(3):553-561.  doi:10.1007/s00262-012-1358-6.
  58. Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol. 2009;9:65.  doi:10.1186/1471-230x-9-65.
  59. Shen Z, Zhou S, Wang Y, Li RL, Zhong C, Liang C, Sun Y. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol. 2010;136(10):1585-1595. doi:10.1007/s00432-010-0816-9.
  60. Viola A, Contento RL, Molon B. T cells and their partners: the chemokine dating agency. Trends Immunol. 2006; 27:421-427.  doi:http://dx.doi.org/10.1016/j.it.2006.07.004.
  61. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother. 2011;60(10):1419-1430. doi:10.1007/s00262-011-1028-0.
  62. Liu VC, Wong LY, Jang T, Shah AH, Park I, Yang X et al. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGFbeta. J Immunol. 2007;178:2883-2892. doi:10.4049/jimmunol.178.5.2883.
  63. Yuan XL, Chen L, Zhang TT, Ma YH, Zhou YL, Zhao Y et al. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1. World J Gastroenterol. 2011;17(15):2019-2027. doi:10.3748/wjg.v17.i15.2019.
  64. Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol. 2014;20(16):4586-4596. doi:10.3748/wjg.v20.i16.4586.
  65. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 2005;102(51):18538-18543. doi:10.1073/pnas.0509182102.
  66. Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, Kim WH. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer. 2008;99(10):1704-1711. doi:10.1038/sj.bjc.6604738.
  67. Owen JL, Mohamadzadeh M. Macrophages and chemokines as mediators of angiogenesis. Front Physiol. 2013;4:159.  doi:10.3389/fphys.2013.00159.
  68. Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014;5:75.  doi:10.3389/fphys.2014.00075.
  69. Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med. 2011;9:216.  doi:10.1186/1479-5876-9-216.
  70. Pantano F, Berti P, Guida FM, Perrone G, Vincenzi B, Amato MM et al. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients. J Cell Mol Med. 2013;17(11):1415-1421. doi:10.1111/jcmm.12109.
  71. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA. 2002;99:345-350.  doi:10.1073/pnas.012511599.
  72. Hagemann T, Robinson SC, Thompson RG, Charles K, Kulbe H, Balkwill FR. Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol Cancer Ther. 2007;6(7):1993-2002. doi:10.1158/1535-7163.mct-07-0118.
  73. Kim KJ, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH, Kang GH. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsate-­llite-unstable gastric cancers. Hum Pathol. 2014;45(2):285-293.  doi:10.1016/j.humpath.2013.09.004.
  74. Milasiene V, Stratilatovas E, Norkiene V. The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients. Medicina (Kaunas). 2007;43(7):548-554. Available at: http://medicina.lsmuni.lt/med/0707/0707-05e.pdf. Accessed June 15, 2015.
  75. Peng LS, Zhuang Y, Shi Y, Zhao YL, Wang TT, Chen N et al. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer. Cancer Immunol Immunother. 2012;61(11):2183-2192. doi:10.1007/s00262-012-1277-6.
  76. Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH, Chen W et al. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology. 2012;143(4):951-962.  doi:10.1053/j.gastro.2012.06.010.
  77. Perrone G, Ruffini PA, Catalano V, Spino C, Santini D, Muretto P et al. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer. 2008;44(13):1875-1882. doi:10.1016/j.ejca.2008.05.017.
  78. Ma GF, Miao Q, Liu YM, Gao H, Lian JJ, Wang YN et al. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment. Br J Cancer. 2014;110(6):1552-1560. doi:10.1038/bjc.2014.47.
  79. Wang B, Xu D, Yu X, Ding T, Rao H, Zhan Y et al. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann Surg Oncol. 2011;18(9):2585-2593. doi:10.1245/s10434-011-1609-3.
  80. Pantano F, Berti P, Guida FM, Perrone G, Vincenzi B, Amato MM et al. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients. J Cell Mol Med. 2013;17(11):1415-1421. doi:10.1111/jcmm.12109.
  81. Kawahara A, Hattori S, Akiba J, Nakashima K, Taira T, Watari K et al. Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep. 2010;24(2):405-415.  doi:10.3892/or_00000873.
  82. Huang KH, Wang RF, Yang MH, Wu CW, Fang WL, Li AF et al. Advanced gastric cancer patients with lymphoid stroma have better survival than those without. J Surg Oncol. 2013;107(5):523-528.  doi:10.1002/jso.23279.
  83. Yang S, Lee H, Pal S, Jove V, Deng J, Zhang W et al. B cells promote tumor progression via STAT3 regulated-angiogenesis. PLoS One. 2013;8(5):e64159. doi:10.1371/journal.pone.0064159.
  84. Wong SC, Puaux AL, Chittezhath M, Shalova I, Kajiji TS, Wang X et al. Macrophage polarization to a unique phenotype driven by B cells. Eur J Immunol. 2010;40(8):2296-2307. doi:10.1002/eji.200940288.
  85. Sica A, Porta C, Riboldi E, Locati M. Convergent pathways of macrophage polarization: the role of B cells. Eur J Immunol. 2010;40(8):2131-2133. doi:10.1002/eji.201040736.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.